Startup Trana Discovery closes on $720,000 in angel funding
Trana Discovery
On The Web
Site Search
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
CARY, N.C. – Startup Trana Discovery, a venture focused on drug discovery technology{{/a}}, has closed on $720,000 in angel funding.
The company plans to use the Series A venture capital funding to commercialize its technology.
The new funding comes on the heels of the recent winning of a $700,000 compound screening contract from the National Institutes of Health’s Institute of Allergy and Infectious Diseases.
Under terms of that contract, Trana is screening some 300,000 compounds from the Southern Research Institute/
Trana’s technology identifies compounds that can inhibit the ability of a pathogen to propagate. The company recently conducted a pilot test of compounds that could combat HIV. Trana licensed the technology from North Carolina State University.
Gary Shipman, managing partner at Wilmington-based law firm Shipman & Wright, helped Trana raise the funding and is now a member of the Trana board.
"We are delighted to welcome Gary as a new board member,” said Trana Chief Executive Officer Steve Peterson. “He was instrumental in securing the funding that we believe will take us to a cash-positive position”
Copyright 2012 WRAL Tech Wire. All rights reserved.
Featured
E-mail Preferences
The Skinny
- What brands are winning Super Bowl hype? Two Durham firms to find out
- In Super Bowl of social media, Patriots win, Triangle firm says
- Big job cuts coming at IBM? Don't be surprised
- Erskine Bowles is among those who can cash in big time on Facebook IPO
- Ignore Facebook hype - Check out 'risk factors,' too
- Facebook vs. Google IPO: Which deal ranks better?
- Triangle StartUp Factory says business already booming
- Entrepreneurship remains at heart of Tech Wire mission
- Flashback: Tech Wire launched 10 years ago today
- Silicon Valley's 'most provocative voice' - Former RTP exec Vivek Wadhwa